The Effects of Neurexin-1 Deficiency on Behavioural Phenotypes Relevant to Schizophrenia and Autism Spectrum Disorder
The Effects of Neurexin-1 Deficiency on Behavioural Phenotypes Relevant to Schizophrenia and Autism Spectrum Disorder
批准号:
G0900625/1
负责人:
Steven Clapcote
金额:
$28.08万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2010
资助国家:
英国
项目状态:
已结题
起止时间:
2010 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Autism spectrum disorders (ASDs) and schizophrenia are forms of mental illness that have profound, long-term impacts on the very many who will be affected in their lifetimes. Both conditions are poorly treated, in part because we know little about the root causes. However, we do know that these illnesses can be inherited, suggesting that defective genes might be involved. This project looks at one particular gene neurexin 1alpha, which was recently discovered to be damaged in some ASD and schizophrenia patients. Working out how the faulty neurexin 1alpha gene might predispose to ASD and schizophrenia is difficult because we can?t ever do the necessary studies in patients. But it turns out that a strain of laboratory mouse also has a faulty neurexin 1alpha gene that mimics the gene defect in patients. So we will use these neurexin 1alpha mutant mice to try to learn more about the role of neurexin 1alpha in ASD and schizophrenia, which might give us clues to better treatments and prevention strategies in the future.Behavioural tests are the most appropriate for investigating the link between the faulty neurexin 1alpha gene and ASD and schizophrenia because abnormal behaviours are the primary symptoms of both disorders. While mental illnesses cannot be replicated in mice, specially-designed behavioural tests can detect behavioural abnormalities in mice that resemble human psychiatric symptoms. We will use this approach to identify the behavioural effects of the faulty neurexin 1alpha gene in mice.At the end of this project, we expect to have identified the ASD- and schizophrenia-related behavioural changes caused by the faulty neurexin 1alpha in mice, generated evidence to help us understand the link between neurexin 1alpha gene defects and mental illness in humans, and determined whether neurexin 1alpha mutant mice exhibit a resemblance to symptoms of ASD or schizophrenia so that they can be used to investigate disease causes and novel treatments in future studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMPC: Disruption of PDZD8 as a potential cause of intellectual disability
-
批准号:MR/R014736/1
-
项目类别:Research Grant
-
资助金额:$4.34万
-
财政年份:2018
-
负责人:Steven Clapcote
-
依托单位:
Effects of specific inhibition of PDE4B on senescence-associated cognitive decline
-
批准号:BB/R019401/1
-
项目类别:Research Grant
-
资助金额:$56.46万
-
财政年份:2018
-
负责人:Steven Clapcote
-
依托单位:
Identification of Major Risk Alleles for Schizophrenia in Consanguineous Families
-
批准号:MR/J004391/1
-
项目类别:Research Grant
-
资助金额:$41.98万
-
财政年份:2012
-
负责人:Steven Clapcote
-
依托单位:
国内基金
海外基金
登录
查看更多内容
硫酸乙酰肝素聚糖修饰Neurexin及其调控的Neurexin/Neuroligin通路在慢性应激所致认知障碍中的作用
-
批准号:82301355
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:沈军
-
依托单位:
基于acRIP-seq技术探究骨癌痛大鼠脊髓背角转录后调控Neurexin2表达的lncRNA分子机制
-
批准号:LTGC23H090002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:徐龙生
-
依托单位:
果蝇Neurexin磷酸化在突触发育和活动依赖可塑性中的作用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:耿俊华
-
依托单位:
Neurexin选择性剪接调控突触编码的分子机制研究
-
批准号:32230039
-
项目类别:重点项目
-
资助金额:272万元
-
批准年份:2022
-
负责人:韩俊海
-
依托单位:
NAT10调控Neurexin2 mRNA乙酰化介导骨癌痛的机制研究
-
批准号:82001176
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:徐龙生
-
依托单位:
力学-化学耦合调控神经突触膜蛋白Neurexin/Neuroligin相互作用的分子机制研究
-
批准号:12002307
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:胡炜
-
依托单位:
突触前膜轴突蛋白Neurexin1基因突变在癫痫共病精神障碍中的作用及机制研究
-
批准号:81971203
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陈子怡
-
依托单位:
Neurexin-1β/neuroligin-2介导神经微环路兴奋-抑制失衡在神经病理性疼痛与抑郁共病中的作用
-
批准号:81901139
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王星明
-
依托单位:
Neuroligin/Neurexin—Kalirin-7介导突触重塑在瑞芬太尼痛觉过敏中的调控机制
-
批准号:81801107
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:张麟临
-
依托单位:
突触粘附分子Neurexin调控恐惧记忆形成的机制研究
-
批准号:31871028
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:江漫
-
依托单位: